BackGlycoMimetics Overview

GlycoMimetics Long Term Debt

Track GlycoMimetics's long-term debt ($970K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$966000.00
32.59% YoYΔ $-467000.00 vs prior year quarter

Peer trimmed avg / median

Loading

GlycoMimetics Long Term Debt History

Loading

GlycoMimetics vs. peers: Long Term Debt Comparison

Loading

GlycoMimetics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GlycoMimetics (GLYC) FAQ

The latest long-term debt for GLYC is $970K as of June 2026. That compares with $1.4M in the prior-year period — down 32.6% year over year. Investors often review this figure alongside GlycoMimetics's historical trend and sector peers before judging valuation or financial health.

Over the past year, GLYC's long-term debt moved from $1.4M to $970K — a 32.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in GlycoMimetics's operating scale or balance-sheet position.

A long-term debt figure of $970K for GLYC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GLYC's long-term debt ($970K), review year-over-year change from $1.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack GlycoMimetics's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.